Search Results
Jun 15, 2026, 08:00 ET Ramaco Resources Announces Second Quarter Class B Stock Dividend Details
2026, which was $11.43 per share (the "Class B Closing Price"). Based on the Class B Closing Price, each Class B common stockholder will receive 0.011977 of one share of Class B common stock for each share of Class B common stock held by the Class B common stockholder at the close of the market
More news about: Ramaco Resources, Inc.
Jun 15, 2026, 08:00 ET FDA grants Monoamine Oxidase Deficiency Orphan Drug Designation
treatment options. MAOD is an X-linked genetic condition caused by impaired activity or the total lack of the monoamine oxidase A and/or monoamine oxidase B enzymes, which play a critical role in regulating neurotransmitters such as serotonin, dopamine, and norepinephrine. Disruption of these pathways leads
More news about: Monoamine Oxidase Deficiency Foundation
Jun 15, 2026, 08:00 ET Halia Therapeutics Receives FDA Fast Track Designation for Ofirnoflast (HT-6184) in Lower-Risk Myelodysplastic Syndromes
events occurring in only 5.4% of patients. Activity was mutation agnostic and observed across WHO MDS subtypes, including patients with and without SF3B1 mutations or del(5q)Halia is currently planning the next stage of clinical development for ofirnoflast in lower-risk MDS and intends to leverage
More news about: Halia Therapeutics
Jun 15, 2026, 07:55 ET JinkoSolar Earns RETC's "Overall Highest Achiever" Award for the Seventh Consecutive Year
confidence that these modules will deliver consistent, dependable results in commercial operation.Most notably, JinkoSolar's next-generation EAGLE G7B module, featuring industry-leading TOPCon technology, earned the Highest Achiever recognition across all categories, demonstrating the Company's continued
More news about: JinkoSolar Holding Co., Ltd.
Jun 15, 2026, 07:45 ET TuHURA Biosciences Files Investigational New Drug Application for Evaluation of the TBS-2025 VISTA Inhibiting Antibody in Molecularly Defined Subsets of AML and Other Blood Related Cancers
provide written responses to questions and information related to the Company's proposed Phase 1b/2 development plan for TBS-2025 in AML The Company is targeting initiation of the Phase 1b/2 study in the second half of 2026TAMPA, Fla.,
More news about: TuHURA Biosciences, Inc.
Jun 15, 2026, 07:31 ET BRC Group Holdings, Inc. Provides Update on SpaceX Carried Interest Position
BRC Group Holdings, Inc. (formerly B. Riley Financial, Inc.) Provides Update on SpaceX Carried Interest PositionBetween 2018 and 2021, the Company's wealth management business
More news about: BRC Group Holdings, Inc.
Jun 15, 2026, 07:04 ET FOX CORPORATION TO ACQUIRE ROKU, INC.
transaction valued at $160.00 per ROKU share. FOX will pay $96.00 in cash and 0.9693 shares of FOX Class A common stock for each Roku Class A and Class B share outstanding immediately prior to the effective time of the merger. The stock consideration represents $64.00 per ROKU share based on a reference
More news about: Fox Corporation
Jun 15, 2026, 07:02 ET APP Group Highlights the Role of Sustainable Products for Hospitality and F&B Ahead of World Cup 2026
responsible, and ready for high-volume service environments."Foopak, APP Group's paperboard brand, provides certified, eco-friendly packaging for F&B businesses. Foopak Bio Natura is a plastic-free, PFAS-free, and compostable solution safe for direct food contact. Designed for high-volume applications
More news about: APP Group
Jun 15, 2026, 07:00 ET Indiana Earns Top Marks, New York Falls Short: Realtor.com®'s 2026 State Report Cards for Homebuilding, Affordability Reveal a Nation Divided
Carolina (B+, 68.6) mirrors South Carolina's building success, with a permit-to-population ratio of 1.84 and a slightly negative new construction premium of -1.5%, meaning builders are delivering homes priced just below existing inventory.The Regional Divide: Every A and B Grade Belongs
More news about: Realtor.com
Jun 15, 2026, 06:59 ET Automotive Interior Market worth $217.11 billion by 2033 | MarketsandMarkets™
alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.Today, 80%
More news about: MarketsandMarkets
Jun 15, 2026, 06:46 ET Tradr, 스페이스X에 2배 롱 및 숏 레버리지 제공
확대하기 때문에 레버리지를 사용하지 않는 대안보다 더 위험하다는 것을 의미한다. 기초 증권의 변동성은 기초 증권의 수익률만큼, 또는 그보다 더 크게 펀드 수익률에 영향을 미칠 수 있다.펀드 투자자는 (a) 레버리지 사용과 관련된 위험을 이해해야 하며, (b) 인버스 및 레버리지 투자 성과 추구의 결과를 이해해야 하고, (c) 숏 ETF의 경우 공매도 위험을 이해해야 하며, (d) 자신의 투자를 적극적으로 모니터링하고 관리할 의사가 있어야 한다. 펀드 성과는 지정된 재설정 기간보다 긴 기간에서는 벤치마크와 상당히 다를 가능성이
More news about: Tradr ETFs
Jun 15, 2026, 06:46 ET Tradr Brings Double Long and Short Leverage to SpaceX
more than, the return of the underlying security.Investors in the fund should: (a) understand the risks associated with the use of leverage; (b) understand the consequences of seeking inverse and leveraged investment results; (c) for short ETFs, understand the risk of shorting; (d) intend to actively
More news about: Tradr ETFs
Jun 15, 2026, 06:40 ET Elevators and Escalators Market worth $114.88 billion by 2031 - Exclusive Report by MarketsandMarkets™
alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.Today, 80%
More news about: MarketsandMarkets
Jun 15, 2026, 06:30 ET VIAVI Launches TETRA MS Base Station Simulator Option for CX300 to Simplify and Speed Mission-Critical Radio Testing
3920B platform."VIAVI has been the benchmark for TETRA radio testing for more than two decades, and the CX300 TETRA MS option is the next step in
More news about: VIAVI Solutions
Jun 15, 2026, 06:30 ET Eminent Announces Mobilization for Drilling at Hot Springs Range Project, Nevada
mobilization.Qualified PersonThe scientific and technical information contained in this news release has been reviewed and approved by Justin B. Milliard, P.Geo., Vice President of Exploration for the Company and a non-independent Qualified Person as defined in National Instrument 43-101 –
More news about: Eminent Gold Corp.
Jun 15, 2026, 06:30 ET Hyperscale Data Announces Advanced Negotiations Toward Executing a Master Services Agreement Expected to Provide 20 Megawatts of Critical AI Compute Capacity at Michigan Data Center Campus Expected to Be Worth in Excess of $1.0 Billion
as-converted basis. The Divestiture will occur through the voluntary exchange of the Series F Preferred Stock for shares of Class A Common Stock and Class B Common Stock of ACG (collectively, the "ACG Shares"). The Company reminds its stockholders that only those holders of the Series F Preferred Stock
More news about: Hyperscale Data Inc.
Jun 15, 2026, 06:00 ET Halozyme Confirms It Projects Zero to Minimal Impact to Royalty Revenue Through At Least 2035 Based on Newly Released Draft Medicare Drug Price Negotiation Program Proposed Rule for IPAY 2029
including statements concerning expectations of the impact on future royalty revenues as a result of implementation of IPAY price negotiations for Part B drugs, and the assumptions used in deriving these projections, and factors such as orphan drug status and the potential launch of biosimilars resulting
More news about: Halozyme Therapeutics, Inc.
Jun 15, 2026, 06:00 ET IDEAYA Biosciences Announces IDE892, a Potential Best-in-Class MTA-Cooperative PRMT5 Inhibitor, Initiates a Phase 1/2 Clinical Combination Study in MTAP-Deleted Pancreatic and Lung Cancers
propertiesIDE892 has a CYP3A4 IC50 greater than 45 micromolar, and did not show time dependent inhibition of any of the 7 major cytochrome P450s (CYP1A2, CYP2B6, CYP2C8, CYP2C9, CYP2C19, CYP2D6, CYP3A4) based on full kinetic CYP inactivation assaysIDE892 monotherapy Phase 1 escalation has cleared multiple
More news about: IDEAYA Biosciences, Inc.
Jun 15, 2026, 04:51 ET Xứng Đáng Được Tỏa Sáng: Giải Đấu Lắp Đặt Điều Hòa Midea Trở Lại với Quy Mô Hoành Tràn và Tổng Giải Thưởng Hấp Dẫn Lên Đến 25.000 USD
multimedia:https://www.prnewswire.com/vn/news-releases/u0078u1EE9u006Eu0067u002Du0111u0061u006Eu0067u002Du0111u01B0u1EE3u0063u002Du0074u1ECFu0061u002Du0073u0061u006Eu0067u003Au002Du0067u0069u1EA3-302800130.htmlSOURCE
More news about: Midea Club
Jun 15, 2026, 04:08 ET Truecaller's Board of Directors has resolved to resume the repurchase of shares
46,783,800 A shares and 288,642,497 B shares and 2,089,498 C shares. All C shares have been repurchased by Truecaller to secure the company's commitments in incentive programs decided by Truecallers Annual General Meetings.As of today Truecaller holds 7,850,000 B shares and 2,089,498 C shares in
More news about: Truecaller AB
Jun 15, 2026, 04:02 ET RBLX Investors Have Opportunity to Lead Roblox Corporation Securities Fraud Lawsuit with the Schall Law Firm
RBLX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
More news about: The Schall Law Firm
Jun 15, 2026, 04:00 ET 선레이트, 여행업계에 엔드투엔드 결제 역량 제공 위해 세이버와 전략적 협력 강화 발표
content:https://www.prnewswire.com/kr/news-releases/uC120uB808uC774uD2B8u002Cu002DuC5ECuD589uC5C5uACC4uC5D0u002DuC5D4uB4DCuD22CuC5D4uB4DCu002DuACB0uC81Cu002DuC5EDuB7C9u002DuC81CuACF5u002DuC704-302780941.htmlSOURCE
More news about: Sunrate
Jun 15, 2026, 03:59 ET VRRM Investors Have Opportunity to Lead Verra Mobility Corporation Securities Fraud Lawsuit with the Schall Law Firm
VRRM) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
More news about: The Schall Law Firm
Jun 15, 2026, 03:57 ET GRAL Investors Have Opportunity to Lead GRAIL, Inc. Securities Fraud Lawsuit with the Schall Law Firm
investors of a class action lawsuit against GRAIL, Inc. ("Grail" or "the Company") (NASDAQ: GRAL) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
More news about: The Schall Law Firm
Jun 15, 2026, 03:54 ET LCID Investors Have Opportunity to Lead Lucid Group, Inc. Securities Fraud Lawsuit with the Schall Law Firm
LCID) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
More news about: The Schall Law Firm